{
  "actions": [
    {
      "acted_at": "2015-02-27", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2015-02-27", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to House Energy and Commerce", 
      "type": "referral"
    }, 
    {
      "acted_at": "2015-02-27", 
      "committees": [
        "HSJU"
      ], 
      "references": [], 
      "text": "Referred to House Judiciary", 
      "type": "referral"
    }, 
    {
      "acted_at": "2015-03-06", 
      "in_committee": null, 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2015-03-31", 
      "committees": [
        "HSHM"
      ], 
      "in_committee": null, 
      "references": [], 
      "text": "Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr1186-114", 
  "bill_type": "hr", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Judiciary", 
      "committee_id": "HSJU"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Judiciary", 
      "committee_id": "HSJU", 
      "subcommittee": "Subcommittee on Crime, Terrorism, Homeland Security, and Investigations", 
      "subcommittee_id": "08"
    }
  ], 
  "congress": "114", 
  "cosponsors": [
    {
      "district": "28", 
      "name": "Cuellar, Henry", 
      "sponsored_at": "2015-09-25", 
      "state": "TX", 
      "thomas_id": "01807", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Norton, Eleanor Holmes", 
      "sponsored_at": "2015-07-14", 
      "state": "DC", 
      "thomas_id": "00868", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2015-02-27", 
  "number": "1186", 
  "official_title": "To amend the Controlled Substances Act relating to controlled substance analogues.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "s1327-114", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "SALTS Act", 
  "sponsor": {
    "district": "13", 
    "name": "Thornberry, Mac", 
    "state": "TX", 
    "thomas_id": "01155", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2015-02-27", 
  "subjects": [
    "Crime and law enforcement", 
    "Drug trafficking and controlled substances", 
    "Drug, alcohol, tobacco use", 
    "Evidence and witnesses", 
    "Marketing and advertising"
  ], 
  "subjects_top_term": "Crime and law enforcement", 
  "summary": {
    "as": "Introduced", 
    "date": "2015-02-27", 
    "text": "Synthetic Abuse and Labeling of Toxic Substances Act of 2015 or the SALTS Act\n\nAmends the Controlled Substances Act to authorize the following factors to be considered in determining whether a controlled substance analogue was intended for human consumption:\n\n the marketing, advertising, and labeling of the substance; the known efficacy or usefulness of the substance for the marketed, advertised, or labeled purpose; the difference between the price at which the substance is sold and the price at which the substance it is purported to be or advertised as is normally sold; the diversion of the substance from legitimate channels and the clandestine importation, manufacture, or distribution of the substance; whether the defendant knew or should have known that the substance was intended to be consumed by injection, inhalation, ingestion, or any other immediate means; and whether the substance is manufactured, formulated, sold, distributed, or marketed with the intent to avoid the provisions of existing drug laws. Declares that evidence that a substance was not marketed, advertised, or labeled for human consumption shall not by itself be sufficient to establish that the substance was not intended for human consumption."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "SALTS Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Synthetic Abuse and Labeling of Toxic Substances Act of 2015", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Controlled Substances Act relating to controlled substance analogues.", 
      "type": "official"
    }
  ], 
  "updated_at": "2016-06-25T06:33:13-04:00", 
  "url": "http://thomas.loc.gov/cgi-bin/bdquery/z?d114:HR1186:@@@L&summ2=m&"
}